Literature DB >> 7532339

Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease.

G W Huntley1, J C Vickers, J H Morrison.   

Abstract

Excitatory amino acid (EAA) receptors are an important component of neocortical circuitry as a result of their role as the principal mediators of excitatory synaptic activity, as well as their involvement in use-dependent modifications of synaptic efficacy, excitoxicity and cell death. The diversity in the effects generated by EAA-receptor activation can be attributed to multiple receptor subtypes, each of which is composed of multimeric assemblies of functionally distinct receptor subunits. The use of subunit-specific antibodies and molecular probes now makes it feasible to localize individual receptor subunits anatomically with a high level of cellular and synaptic resolution. Initial studies of the distribution of immunocytochemically localized EAA-receptor subunits suggest that particular subunit combinations exhibit a differential cellular, laminar and regional distribution in the neocortex. While such patterns might indicate that the functional heterogeneity of EAA-receptor-linked circuits, and the cell types in which they operate, are based partly on differential subunit parcellation, a definitive integration of these anatomical details into current schemes of cortical circuitry and organization awaits many further studies. Ideally, such studies should link a high level of molecular precision regarding subunit localization with synaptic details of identified connections and neurochemical features of neocortical cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532339     DOI: 10.1016/0166-2236(94)90158-9

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  23 in total

1.  Effect of 2-amino-5-phosphopentanoic acid (AP5), a glutamate NMDA receptor blocker, on neuron activity in the cat motor cortex during performance of a paw placement conditioned reflex.

Authors:  V I Maiorov; B V Chernyshev; A A Moskvitin
Journal:  Neurosci Behav Physiol       Date:  1998 Sep-Oct

2.  Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Authors:  Cynthia Aranow; Betty Diamond; Meggan Mackay
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

3.  Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat.

Authors:  V Bernard; P Somogyi; J P Bolam
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

Review 4.  Cortical chemoarchitecture shapes macroscale effective functional connectivity patterns in macaque cerebral cortex.

Authors:  Elise Turk; Lianne H Scholtens; Martijn P van den Heuvel
Journal:  Hum Brain Mapp       Date:  2016-03-11       Impact factor: 5.038

Review 5.  Integrative neuroscience approach to neuropsychiatric lupus.

Authors:  Patricio T Huerta; Elizabeth L Gibson; Carson Rey; Tomás S Huerta
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

6.  The anticonvulsant effects of the enantiomers of losigamone.

Authors:  F A Jones; J A Davies
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

7.  Short-term synaptic enhancement and long-term potentiation in neocortex.

Authors:  M A Castro-Alamancos; B W Connors
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

8.  The effect of the desglycinyl metabolite of remacemide hydrochloride (FPL 12495AA) and dizocilpine (MK-801) on endogenous amino acid release from mouse cortex.

Authors:  J Srinivasan; A Richens; J A Davies
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

9.  NMDA-dependent and NMDA-independent neural processes in the bicucculline-disinhibited motor cortex of the cat during the acquisition and reproduction of a conditioned paw-on-support placing reflex.

Authors:  V I Maiorov
Journal:  Neurosci Behav Physiol       Date:  2003-05

Review 10.  Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia.

Authors:  Bita Moghaddam
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.